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Dominant negative or haploinsufficient mutations in the collagen genes COL4A1 and COL4A2
are characterized by arterial basement membrane thickening resulting in a multisystem micro-
angiopathy targeting the CNS but also potentially affecting the ocular, renal, cardiac, and mus-
cular systems. Within the brain, such changes predispose affected individuals to recurrent
ischemic and/or hemorrhagic strokes beginning during early fetal development but extending
into the postnatal period and even into adulthood.1 Mutations affecting glycine residues of the
Gly-Xaa-Yaw (typically representing glycine-proline-4-trans-hydroxyproline in vertebrates) re-
peat domains that typify collagens usually manifest in an autosomal dominant (AD) fashion.
However, recent work suggests that tissue-specific mutation effects may also occur, with muta-
tions leading to gain of function effects in some tissues and loss of function effects in others.2
Stroke-related complications may be insidious and clinically silent. Neuroimaging phenotypes of
COL4A-associated disease include chronic whitematter disease, porencephaly/hydranencephaly,
encephalomalacia, cerebral calcifications, schizencephaly and hydrocephalus and corresponding
clinical diagnoses of cerebral palsy, intellectual disability, cortical visual impairment, and epilepsy.3
Type IV collagen α chains form heterotrimers with β chains in a 2:1 ratio, and incompletely
penetrant AD inheritance is typical. Although autosomal recessive mutations of COL4A1 have
been described,4 prior reports of COL4A2-associated disease have all featured AD inheritance.
We describe 2 children from a consanguineous Iranian family with intellectual disability, spastic
cerebral palsy, and epilepsy who each harbored the same homozygous mutation in COL4A2.
Pregnancies for both children were uncomplicated, and both were born at term by vaginal
delivery. The couple’s 8 year-old son was bedridden and exhibited cortical visual impairment.
He did not fix or track stimuli. He had never been able to sit unassisted or control his head. He
did not speak or demonstrate communicative intent. He had focal epilepsy that began at age 6
months, partially controlled with carbamazepine. Motor examination revealed spastic quadri-
plegia with ophthalmoplegia, nystagmus, and skew deviation. Brain MRI revealed bilateral
colpocephaly and irregular ventricular contours. His sister was 20 years old at the time of
evaluation. Milestone attainment had been globally delayed. She also had focal epilepsy with
onset at 18months. Seizures were controlled with phenobarbital and carbamazepine. She began
walking independently at age 3 years. At the time of evaluation, she did not speak, and her
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examination was significant for asymmetric spastic-dystonic
quadriparesis with right-sided predominance. Her brain MRI
showed irregular lateral ventricle contour with coalescent
porencephaly and generalized cortical atrophy (figure, A).
Neither patient was known to have ocular, kidney, skeletal, or
cardiac muscle disease.
Both affected children and their parents provided informed
consent for study participation in accordance with local ethics
oversight and underwent whole-exome sequencing with fil-
tering and variant prioritization as described previously.5 This
revealed a homozygous c.3472G>C (p.G1158R) variant in
COL4A2 (NM_001846) segregating with disease status in the
family (both parents are neurologically healthy, although
neuroimaging was not able to be performed) (figure, B). This
variant is novel (not found in gnomAD or the Greater Middle
Eastern Variome server) and predicted to be deleterious
(MetaSVM, CADD, SIFT, and PolyPhen), putatively by
disrupting a glycine residue within a highly conserved Gly-
Xaa-Yaw collagen triple helix repeat domain. Such glycine
residues are known to be critical determinants of collagen
stability and we anticipate that the substitution of an arginine
residue to have a destabilizing effect.6
In comparison to previously described incompletely pene-
trant dominantly inherited mutations in COL4A2, this ho-
mozygous (p.G1158R) variant appears to exhibit autosomal
recessive inheritance, although our observations will benefit
from subsequent confirmation. Our results indicate that both
dominant and recessive forms of COL4A2 disease exist. This
finding has potentially important implications for the in-
terpretation of clinical genetic testing in cases of por-
encephaly, hydrocephalus or idiopathic antenatal or perinatal
ischemic/hemorrhagic stroke and for associated clinical
phenotypes including epilepsy, intellectual disability, and ce-
rebral palsy.7
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Figure Clinical, Neuroimaging, and Genetic Findings in the Index Family
(A) Pedigree demonstrating variant segregation. (B) Brain MRI findings from the affected sister demonstrate colpocephaly, irregular ventricular contours,
encephalomalacia affecting the left greater than right caudate, putamen, globus pallidus, and thalamus, periventricular white matter injury, and thin corpus
callosum. (C) Protein schematic with mapping of autosomal dominant mutations previously described and autosomal recessive variant described in this
study (green = collagen triple helices; pink = procollagen C-terminal repeat domain; black variants indicate ischemic disease; red variants indicate hemor-
rhagic disease; purple variants indicate porencephaly; homozygous variant from this study bolded and underlined).
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